Role of NMDA and AMPA glutamate receptors in the induction and the expression of dopamine-mediated sensitization in 6-hydroxydopamine-lesioned rats

Synapse

Volumn 56, Issue 1, 2005, Pages 45-53

  Pollack, Alexia E ^a   St Martin, Jessie L ^a   Macpherson, Alexa T ^a  

^a UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

Author keywords

Fos; Priming; Quinpirole; Rotational behavior; SKF38393; Striatum

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OXIDOPAMINE; QUINPIROLE;

ARTICLE; BRAIN INJURY; CIRCLING BEHAVIOR; DRUG POTENTIATION; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

ANIMALS; CORPUS STRIATUM; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION REGULATION; MALE; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 14644402996     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.20125     Document Type: Article

References (45)

1. Ariano MA, Larson ER, Noblett KL, Sibley DR, Levine MS. 1997. Coexpression of striatal dopamine receptor subtypes and excitatory amino acid subtypes. Synapse 26:400-414.
2. Borowicz KK, Duda AM, Kleinrok Z, Czuczwar SJ. 2001. Interaction of GYKI 52466, a selective non-competitive antagonist of AMPA/kainate receptors, with conventional antiepileptic drugs in amygdala-kindled seizures in rats. Pol J Pharmacol 53:101-108.
3. Byrnes EM, Reilly A, Bruno JP. 1997. Effects of AMPA and D1 receptor activation on striatal and nigral GABA efflux. Synapse 26:254-268.
4. Carey RJ. 1991. Chronic L-DOPA treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance. Brain Res 568:205-214.
5. Engber TM, Anderson JJ, Boldry RC, Kuo S, Chase TN. 1993. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion. Neuroscience 54:1051-1061.
6. Engber TM, Anderson JJ, Boldry RC, Papa SM, Kuo S, Chase TN. 1994. Excitatory amino acid receptor antagonists modify regional cerebral metabolic responses to levodopa in 6-hydroxydopamine-lesioned rats. Neuroscience 59:389-399.
7. Fenu S, Carta A, Morelli M. 1995. Modulation of dopamine D1-mediated turning behavior and striatal c-fos expression by the substantia nigra. Synapse 19:233-240.
8. Gancher S, Mayer A. 1995. Sensitization to apomorphine-induced rotational behavior in 6-OHDA-lesioned rats: effects of NMDA antagonists on drug response. Brain Res 682:63-68.
9. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma Jr FJ, Sibley DR. 1990. D1 and D2 dopamine receptor regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429-1432.
10. Graybiel AM, Moratalla R, Robertson HA. 1990. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosomes-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci U S A 87:6912-6916.
11. Harsing LG, Csillik-Perczel V, Ling I, Solyom S. 2000. Negative allosteric modulators of AMPA-preferring receptors inhibit [(3)H]GABA release in rat striatum. Neurochem Int 37:33-45.
12. Hernandez LF, Segovia G, Mora F. 2003. Effects of NMDA and AMPA glutamate receptors on extracellular concentrations of dopamine, acetylcholine, and GABA in striatum of the awake rat: a microdialysis study. Neurochem Res 28:1819-1827.
13. Hudson JL, van Horne CG, Stromberg I, Brock S, Clayton J, Masserano J, Hoffer BJ, Gerhardt GA. 1993. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res 626:167-174.
14. Kaur S, Starr MS. 1997. Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behavior in the reserpine-treated rat. Neuroscience 76:345-354.
15. Kaur S, Ozer H, Starr MS. 1997. MK-801 reverses haloperidol-induced catalepsy from both striatal and extrastriatal sites in rat brain. Eur J Pharmacol 332:153-160.
16. Keefe KA, Gerfen CR. 1996. D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors. J Comp Neurol 367:165-176.
17. Kreipke CW, Walker PD. 2004. NMDA receptor blockade attenuates locomotion elicited by intrastriatal dopamine D1-receptor stimulation. Synapse 53:28-35.
18. Landwehrmeyer GB, Standaert DG, Testa CM, Penney JB, Young AB. 1995. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J Neurosci 15:5297-5307.
19. Loschmann P-A, Kunow M, Wachtel H. 1992. Synergism of NBQX with dopamine agonists in the 6-OHDA rat model of Parkinson's disease. J Neural Transm 38 (Suppl):55-64.
20. Loschmann P-A, Wullner U, Heneka MT, Schulz JB, Kunow M, Wachtel H, Klockgether T. 1997. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease. Synapse 26:381-391.
21. Marin C, Jimenez A, Bonastre M, Chase TN, Tolosa E. 2000. Non-NMDA receptor-mediated mechanisms are involved in levodopa-induced motor response alterations in Parkinsonian rats. Synapse 36:267-274.
22. Morelli M, Di Chiara G. 1987. Agonist-induced homologous and heterologous sensitization to D1 and D2-dependent contraversive turning. Eur J Pharmacol 141:101-107.
23. Morelli M, Di Chiara G. 1990a. Stereospecific blockade of N-methyl-D-aspartate transmission by MK 801 prevents priming of SKF 38393-induced turning. Psychopharmacology 101:287-288.
24. Morelli M, Di Chiara G. 1990b. MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease. Eur J Pharmacol 182:6110-6112.
25. Morelli M, Fenu S, Garau L, Di Chiara G. 1989. Time and dose dependence of the "priming" of the expression of dopamine receptor supersensitivity. Eur J Pharmacol 162:329-335.
26. Morelli M, Fenu S, Pinna A, Di Chiara G. 1992. Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression. J Pharmacol Exp Ther 260:402-408.
27. Morelli M, Fenu S, Carta A, Di Chiara G. 1996. Effect of MK 801 on priming of D1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen. Behav Brain Res 79:93-100.
28. Parent A, Hazrati LN. 1995. Functional anatomy of the basal ganglia. I. The cortical-basal ganglia-thalamocortical loop. Brain Res Rev 20:91-127.
29. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates, 2nd ed. San Diego: Academic Press.
30. Pollack AE, Haisley EC. 2001. NMDA glutamate receptor stimulation is required for the expression of D2 dopamine mediated responses in apomorphine primed 6-hydroxydopamine lesioned rats. Brain Res 897:213-216.
31. Pollack AE, Strauss JB. 1999. Time dependence and role of N-methyl-D-aspartate glutamate receptors in the priming of D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats. Brain Res 827:160-168.
32. Pollack AE, Yates TM. 1999. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine lesioned rats. Neuroscience 94:504-514.
33. Pollack AE, Turgeon SM, Fink JS. 1997. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine rats. Neuroscience 79:79-93.
34. Ravenscroft P, Brotchie J. 2000. NMDA receptors in the basal ganglia. J Anat 196:577-585.
35. Rouillard C, Bedard P, Falardeau R, Di Paolo T. 1988. Repeated stimulation of D1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion. Eur J Pharmacol 157:125-133.
36. Smith AD, Bolam JP. 1990. Neural networks of the basal ganglia as revealed by the study of synaptic connections of identified neurons. Trends Neurosci 13:259-265.
37. Standaert DG, Testa CM, Young AB, Penney JB. 1994. Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J Comp Neurol 343:1-16.
38. Starr MS. 1995. Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance for Parkinson's disease. Synapse 19:264-293.
39. Svensson TH, Mathe JM. 2000. Atypical antipsychotic-like effect of AMPA receptor antagonists in the rat. Amino Acids 19:221-226.
40. Tallaksen-Greene SJ, Albin RL. 1994. Localization of AMPA-selective excitatory amino acid receptor subunits in identified populations of striatal neurons. Neuroscience 61:509-519.
41. Tallaksen-Greene SJ, Wiley RG, Albin RL. 1992. Localization of striatal excitatory amino acid binding site subtypes to striatonigral projection neurons. Brain Res 594:165-170.
42. Tarazi FI, Baldessarini RJ. 1999. Regional localization of dopamine and ionotropic glutamate receptor subtypes in striatolimbic brain regions. J Neurosci Res 55:401-410.
43. Ungerstedt U. 1971. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367:69-93.
44. Van De Witt S, Groenewegen HJ, Voorn P. 2002. MK-801 alters the effects of priming with L-dopa on dopamine D2 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons. Synapse 43:1-11.
45. Wachtel H, Kunow M, Loschmann P-A. 1992. NBQX (6-nitro-sulfamoyl-benzo- quinoxaline-dione) and CPP (3-carboxy-piperazinepropyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats. Neurosci Lett 142:179-182.